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Abstract
The product of theUL11 gene ofHSV-1 is a small, membrane-bound tegument proteinwith features that are conserved among all herpesviruses. For
all viruses examined, mutants lacking this protein (or its homolog) have budding defects and accumulate capsids in the cytoplasm of the infected cell.
UL11 binds to the cytoplasmic faces of host membranes via N-terminal myristate and nearby palmitate moieties. These fatty-acid modifications are
typical of proteins that localize to detergent-resistant membranes (DRMs), and the experiments described here revealed that a small amount (∼10%) of
UL11 retains the ability to float in sucrose gradients following treatment of cells with Triton X-100. However, mutants lacking sequences previously
shown to be involved in the trafficking of UL11 from the plasma membrane (LI and acidic cluster motifs) were found to have a dramatically increased
association with DRMs. These findings emphasize the dynamic properties of this poorly-understood but conserved tegument protein.
© 2008 Elsevier Inc. All rights reserved.Keywords: UL11; Lipid raft; DRM; Herpes simplex; Acidic cluster; Di-leucine; Myristate; PalmitateIntroduction
The UL11 protein of herpes simplex virus (HSV) is necessary
for the efficient production of virions in cell cultures (Baines and
Roizman, 1992; Fulmer et al., 2007; MacLean et al., 1992). This
small, 96-amino-acid molecule is thought to be made on
cytoplasmic ribosomes, where it is cotranslationally modified
with myristate on its N-terminal glycine following removal of
the initiator methionine (MacLean et al., 1989; Resh, 1999).
UL11 subsequently binds to the cytoplasmic faces of cellular
membranes and becomes palmitylated on at least one of the three
cysteines located near the amino terminus (Baines et al., 1995;
Loomis et al., 2001). Modifications with myristate and palmitate
are needed for the accumulation of UL11 on Golgi-derived
membranes (Bowzard et al., 2000; Loomis et al., 2001), the site
of maturation budding where capsids acquire their envelopes
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doi:10.1016/j.virol.2008.01.007packaged into the virion (Loomis et al., 2006), and these are
thought to extend from the membrane into the tegument, the
region located between the membrane and the capsid (Metten-
leiter, 2004). Mutants having large deletions in the UL11-coding
sequence exhibit an accumulation of unenveloped capsids in the
cytoplasm (Baines and Roizman, 1992; Fulmer et al., 2007;
MacLean et al., 1992). Moreover, all herpesviruses encode a
homolog of UL11, and in those cases where this gene has been
disrupted, replication defects and cytoplasmic capsid accumula-
tions also result (Britt et al., 2004; Kopp et al., 2003, 2004;
Schimmer and Neubauer, 2003; Silva et al., 2003, 2005).
However, in contrast to human cytomegalovirus, where null
mutants are completely defective for the release of extracellular
virions, HSV mutants have been reported to be reduced at most
∼1000 fold, perhaps due to redundancy. Alternatively, this
could be due to incomplete removal of the UL11-coding se-
quence to avoid the overlap with the UL12 gene, thereby leaving
large portions of the N-terminus of UL11 intact (Baines and
Roizman, 1992; Fulmer et al., 2007; MacLean et al., 1992).
Although UL11 mutants have defects in maturation budding,
the actual function of this protein is unknown. Insight was
provided by the discovery of an interaction between UL11 and
Fig. 1. Flotation analysis of UL11. (A) A7 cells transfected with a UL11-GFP
expression vector were metabolically labeled for 2.5 h and osmotically disrupted,
as described in the text. Cytoplasmic membranes were treated with nothing (TM,
total membranes), 0.5% TX-100 (DRM, detergent-resistant membranes), or
0.5% SDS (negative control). The ability of UL11-GFP to float to the upper
fractions of sucrose step gradients during centrifugation was examined, and
representative autoradiograms, obtained following immunoprecipitation and
SDS-PAGE analysis, are shown. As a control for DRM disruption, endogenous
transferrin receptor (TfR) was monitored in one experiment following
radiolabeling, TX-100 treatment, and flotation. The tops and bottoms of the
gradients are indicated. (B) Phosphorimager analysis was used to quantitate the
flotation results, which are shown as the percentage of floating protein (top three
fractions) relative to the total protein (all fractions). The averages of four
experiments are shown, along with the standard deviations. (C) Flotation assays
were used to compare the membrane-binding properties of radiolabeled UL11-
GFP produced in transfected cells with untagged UL11 and UL11-GFP produced
by wild-type and recombinant viruses (HSV and HSV.GFP, respectively). Cells
were labeled for the final 2.5 h of infection, harvested, and floated as described in
the text. The averages from at least four experiments are shown, along with the
standard deviations. (D) To examine the saturability of DRMs, cells were
transfected with increasing amounts of plasmid DNA, metabolically labeled, and
subsequently analyzed for UL11-GFP expression levels (hatched bars; RPU =
relative phosphorimager units) andDRM localization (grey bars). A repeat of this
experiment gave comparable results.
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protein that has been reported to be associated with capsids
(Meckes and Wills, 2007; Oshima et al., 1998). This led to a
model that is reminiscent of the function of viral matrix proteins
in which UL11 links capsids (via UL16) to host membranes to
promote the budding process (Loomis et al., 2003). However, it
is clear that this view is overly simplistic because UL11 mutants
have been found that are incorporated into virions, even though
they lack the LI (leucine–isoleucine) and acidic cluster (AC)
motifs needed for the interaction with UL16 (Loomis et al.,
2006). These motifs are particularly interesting because they are
important for the recovery of UL11 from the plasma membrane
back to internal membranes. That is, when either motif is
absent, a portion of UL11 accumulates at the cell periphery
(Loomis et al., 2001). Moreover, chimeras that have foreign
acidic clusters (from Nef or furin) do not accumulate on the
plasma membrane and are packaged, even though they do not
interact with UL16 (Loomis et al., 2001, 2003, 2006). Based on
these observations, another model for the function of UL11 in
virus assembly can be imagined in which passage through a
particular trafficking pathway is needed (Loomis et al., 2006).
This might enable the recruitment of other proteins (virus or
host encoded) from the plasma membrane, or enable post-
translational modifications of UL11 that are essential for
budding.
In light of the apparent importance of membrane trafficking
for the function of UL11, the ability of this tegument protein to
associate with detergent-resistant membranes (DRMs) was
examined. DRMs are microdomains within cellular membranes
that are enriched in cholesterol and sphingolipids, yielding
“platforms” that are thought to be important for several
functions including signal transduction, cytoskeletal organiza-
tion, and pathogen entry and exit (Anderson and Jacobson,
2002; Chazal and Gerlier, 2003; Helms and Zurzolo, 2004;
Lichtenberg et al., 2005; Ono and Freed, 2005; Pike, 2004;
Simons and Vaz, 2004). DRMs are insoluble in non-ionic
detergents such as Triton X-100 (TX-100), conditions that
disrupt non-DRMmembranes (Lichtenberg et al., 2005; Simons
and Ikonen, 1997; Vitetta et al., 1973). Because of this property,
DRMs can be released by adding TX-100 and purified by
flotation in sucrose gradients, enabling the resident proteins to
be analyzed. Proteins that are dually modified with myristate
and palmitate are typically associated with DRMs (Pike, 2004;
Resh, 1999; Simons and Vaz, 2004), and therefore, we predicted
that UL11 would be, too. The results described below suggest
that a population of UL11 molecules traffics through DRMs
under the control of the LI and acidic cluster motifs.
Results
Flotation analysis of UL11-GFP
Initially, the ability of UL11 to localize to DRMs in the
absence of other viral proteins was examined using a UL11-
GFP fusion protein. This construct has been studied extensively
and appears to behave identically to the untagged protein in all
assays used (Loomis et al., 2001, 2003, 2006). Using metaboliclabeling, membrane binding was determined in the absence of
detergent. Labeling and immunoprecipitations allow an
increased sensitivity, reproducibility, and ability to be quanti-
tative over a wider range of expression levels compared to
Western blots. As expected from previous studies of UL11-GFP
(Loomis et al., 2001), about 80% of the protein was found to
float in the absence of detergent, indicating that it was stably
membrane-bound (Fig. 1A and B). After treatment with TX-
100, only about 10% of the protein could float into the top three
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present during 2.5 h of continuous radiolabeling. Although low,
this amount was above background levels, as determined by
flotation in the presence of 0.5% SDS to solubilize all
membranes (Fig. 1A and B). While this is not a statistically
significant difference from the TX-100 sample (Student's T-test,
P=0.10), if the definition of floating protein is restricted to the top
two fractions (thereby eliminating the possibility of contamination
from the large amount of underlying material that does not
float), then a dramatic increase in statistical significance is seen
(P=0.003). As will be seen below, mutants that disrupt the
trafficking of UL11 result in dramatic differences in DRM
localization, even with the less restrictive definition, and hence, it
was used for the remainder of the experiments.
Two additional experiments provided evidence for the
association of wild-type UL11 with DRMs. In the first, the
flotation property of UL11-GFP was compared with endogen-
ous transferrin receptor (TfR) present in the transfected cells.
TfR is a membrane-bound but DRM-excluded protein, and
when TX-100 was present, the amount of floating material was
found to be only 25% that of UL11-GFP, a difference that was
similar to that seen for UL11-GFP when comparing SDS and
TX-100 treated samples (Fig. 1A and B). Second, when DRMs
were disrupted with the cholesterol chelating drug methyl-β-
cyclodextrin (MβCD; 10 mM), the amount of WT UL11-GFP
localized to DRMs decreased ∼20%. While this is not a
complete abolishment of DRM-bound UL11, not all DRM
resident proteins are completely sensitive to MβCD (Sugawara
et al., 2007).
To ascertain whether the association of UL11-GFP with
DRMs depends on its level of expression, increasing amounts of
the expression vector were transfected into A7 cells. If the
capacity of the cell to create DRMs was saturable, then the
amount of UL11-GFP floating would plateau as expression
continued to increase, and consequently, the percentage of
DRM-associated protein would decrease. This was not found.
Instead, the percentage of DRM-associated protein remained
constant over a 20-fold range of expression (Fig. 1D). Thus, any
variation in UL11-GFP expression between experiments appears
to be unimportant for the studies below. Nevertheless, attempts
were made to keep expression levels equal by transfecting
consistent amounts of DNA (15 μg) for each construct in each
experiment.
Because UL11 has been shown to interact with other HSV
tegument proteins (Farnsworth et al., 2007; Loomis et al., 2003;
Vittone et al., 2005) and such interactions may alter the
localization of UL11, the membrane association of UL11-GFP
during an HSV infection was examined. To this end, a recom-
binant virus was created to express the fusion protein. For
the flotation analyses, A7 cells were infected with the wild-type
or recombinant virus at a multiplicity of infection of 10,
radiolabeled for the final 2.5 h of infection, and osmotically
disrupted at early (10–12 h) or late (18–20 h) times post-
infection. In all cases, the flotation properties for virus-encoded
UL11 and UL11-GFP were similar to that of transfected-only
UL11-GFP (Fig. 1C). These results demonstrate that other viral
proteins do not influence the DRM distribution of UL11; nordoes the attachment of GFP (which by itself did not float; data
not shown). Given this, all subsequent experiments were
performed in the absence of all other viral proteins and in the
context of a GFP fusion protein.
Specificity of the UL11 antibody
It was of concern that one or more of the mutants used in
these studies (Fig. 2A) would lack epitopes needed for efficient
recognition by the previously-described, UL11-specific anti-
body employed here (Loomis et al., 2003). Therefore, the ability
of this antibody to immunoprecipitate the various UL11-GFP
derivatives was compared to that of an anti-GFP antibody. All
constructs were immunoprecipitated with equal efficiency using
either antibody (Fig. 2B).
Role of fatty-acid modification
Based on studies of other proteins, dual modification with
myristate and palmitate is predicted to be essential for DRM
targeting of UL11 (Pike, 2004; Resh, 1999; Simons and Vaz,
2004). To test this, mutants that lack these modifications were
analyzed. Mutant Myr(−), which lacks the site for myristylation
and therefore fails to reach membranes where palmitylation
occurs (Greaves and Chamberlain, 2007; Linder and
Deschenes, 2007; Resh, 1999), behaved as expected and was
not associated with any membranes, including DRMs (Fig. 2C).
Likewise, mutant CCC(−), which is myristylated but lacks sites
for palmitylation (Loomis et al., 2001), would be expected to
retain some capacity to associate with membranes but not to be
associated with DRMs, and that is what was found. Even
though 45% of the CCC(−) molecules were able to float in the
absence of TX-100, only 1% was DRM-associated (Fig. 2C),
which is equivalent to the background levels seen for wild-type
when SDS was used (Fig. 1B). These data support the
hypothesis that myristate alone is capable of directing UL11
to membranes, whereas both palmitate and myristate are
required for the targeting of UL11 to DRMs.
To attempt rescue of the Myr(−) and CCC(−) mutants into
DRMs, previously-constructed chimeras (Loomis et al., 2001)
were examined that have the first 10 amino acids of the v-Src or
Fyn proteins added to the N-terminus of UL11-GFP (mutants
sUL11 and fUL11, respectively; Fig. 3). Attachment of these
peptides precludes myristylation of the N-terminal glycine of
UL11, however, both foreign sequences have their own site for
this modification (Resh, 1999). In addition, each has character-
istics that increase membrane-binding. The v-Src peptide has
three basic residues that interact with acidic phospholipids on
the cytoplasmic faces of membranes (Resh, 1999). In addition
to basic residues, the Fyn peptide has two cysteine residues that
can be palmitylated (Alland et al., 1994; Resh, 1999; Shenoy-
Scaria et al., 1994). The membrane-binding properties of these
two chimeras (i.e., without other alterations to UL11) were
examined first. As expected, sUL11 and fUL11 were about 80%
membrane associated in the absence of detergent (Fig. 3A and
B, respectively). When the membranes were treated with TX-
100, sUL11 was found to be associated with DRMs to an extent
Fig. 3. Analyses of N-terminal UL11 chimeras. N-terminal extensions
corresponding to the first 10 amino acids of (A) Src or (B) Fyn were attached
to UL11-GFP, as represented by the shaded boxes in the diagrams. Wavy lines
denote fatty-acid modifications and “+” indicates basic residues. These N-
terminal chimeras and the indicated mutants (defined in Fig. 2A) were analyzed
for their ability to float in the absence (TM) and presence (DRM) of 0.5% TX-
100. Each construct was analyzed a minimum of three times.
Fig. 2. DRM association of UL11 mutants. (A) Diagram of UL11-GFP and the
mutants that were analyzed. The motifs of interest are shown: G, myristylation
site; CCC, palmitylation site; LI, di-leucine-like; DIESEEE, acidic cluster (AC).
Sites of alanine substitutions are indicated. (B) To examine the reactivity of the
mutants to anti-UL11 and anti-GFP sera, transfected cells were metabolically
labeled and immunoprecipitated proteins were analyzed by SDS-PAGE. The
positions of the UL11-GFP species are indicated with a bracket to the left.
Positions of markers (in kDa) are indicated to the right. (C) Constructs depicted in
panel Awere analyzed for their ability to float in the absence (TM) and presence
(DRM) of 0.5% TX-100. Each construct was analyzed a minimum of three times.
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target DRMs is apparently due to palmitylation of one or more
of the UL11 cysteines because when these were eliminated in
mutant sCCC(−), DRM association dropped to background
levels. In contrast, the association of fUL11 with DRMs was
increased ∼3-fold compared to UL11-GFP, perhaps due to
palmitylation of the extra cysteine residues present in the Fyn
peptide. However, even in this case, the cysteines in UL11
appear to contribute to DRM association because when these
were eliminated in mutant fCCC(−), levels dropped to that of
wild-type UL11-GFP.Sequences that control levels of DRM association
Although myristate and palmitate are essential for the
accumulation of UL11-GFP within DRMs, it is possible that
other parts of the protein actually control its trafficking through
these membrane locations (e.g., by enabling interactions with
cellular factors to enable endocytosis). If so, these functions
must reside in the first half of UL11 because mutant Δ51–96,
which lacks the second half, was indistinguishable from wild-
type in the flotation assays (Fig. 2C). The obvious elements to
examine were the LI and the acidic cluster motifs. To analyze
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leucine–isoleucine motif [mutant LI(−), changed to alanines] or
the acidic cluster motif [mutant AC(−), deletion of the seven-
residue cluster] were used (Loomis et al., 2001, 2003). Addition-
ally, a third variant of UL11, which combines both mutations,
was used (mutant LI/AC(−); Fig. 2A). Elimination of either of
these motifs alone from UL11-GFP had small enhancing effects
on DRM association, but when both motifs were missing, a
striking 3-fold increase occurred (Fig. 2C). These results are
consistent with the hypothesis that either motif is sufficient to
enable UL11 to exit DRMs, perhaps through either of two
different pathways. This model is reminiscent of the dual-
pathway trafficking found for the Nef protein of HIV in which
LL and acidic cluster motifs are separately utilized for down-
regulation of CD4 (the virus receptor) and the major histocom-
patibility complex class I, respectively (Doms and Trono, 2000;
Roeth and Collins, 2006).
The LI and acidic cluster mutants of UL11-GFP were also
examined in the context of the chimeras. Addition of the v-Src
peptide appears to make UL11 more sensitive to removal of the
trafficking motifs in that enhanced DRM association occurred
even with the single mutations (Fig. 3A). In contrast, DRM
association of the Fyn chimera appears to be controlled primarily
by the acidic cluster. That is, removal of the acidic cluster (alone
or in combination with the LI substitution) resulted in an
increase, whereas removal of the LI resulted in at most a small
reduction in DRM accumulation. Collectively, these complex
results suggest that the foreign sequences may interfere with the
normal trafficking properties of UL11, possibly by altering the
conformation and hence the ability of the LI and acidic cluster
motifs to be properly recognized by the sorting machinery.
Discussion
The experiments described here demonstrate that the
association of UL11 with DRMs requires the addition of both
myristate and palmitate. This is consistent with UL11 of HSV-2
(Koshizuka et al., 2007); however, this report extends our
understanding by demonstrating the importance of the LI and
acidic cluster motifs to further regulate membrane association.
The increase in DRM accumulation seen when both the LI and
the AC motifs were removed could be due to either enhanced
entry or inhibited exit from DRMs; however, the latter seems
more reasonable for two reasons. First, the combination of
myristate and palmitate appear to function as “enter” signals for
DRMs (Pike, 2004; Resh, 1999; Simons and Vaz, 2004).
Second, acidic clusters and di-leucine-like motifs are well
established signals involved in exit and the recovery of various
proteins off the plasma membrane (Bonifacino and Traub, 2003;
Heilker et al., 1999), and previous studies have shown that
removal of either motif in the context of a CD4-UL11 chimera
results in accumulation of the mutant on the cell surface (Loomis
et al., 2001). While it would be very interesting to examine the
above chimeras andmutant alleles in the context of the virus, this
is not possible due to the overlap of UL11with the essential UL12
gene.Moreover, a complete knock-out of the gene is not possible
either, and this is why the deletion viruses that have been createdretain most of the described motifs, possibly explaining the
“mild” decrease in viral titer (∼1000-fold).
Given these data, why does UL11 traffic to the plasma
membrane and DRMs? At least three possibilities can be
imagined. First, there might not be any function for UL11 on
the plasmamembrane, and a recoverymechanismmay be needed
merely to return this protein to the site of budding whenever it
happens to escape to the cell periphery. The problem with this
model is that it does not explain why UL11 contains two
recycling motifs (Loomis et al., 2001), only one of which is
needed for packaging (Loomis et al., 2006). In light of the
similarity with the Nef protein (mentioned above), a second
model emerges in which UL11 travels to the plasma membrane
and back to internalmembranes for one ormore specific purposes
(e.g., to downregulate a host protein, to acquire a modification, or
to bring another protein to the site of budding). This could be the
sole purpose for UL11, or it could be a function that is needed in
addition to bridging connections between capsids and mem-
branes. A third possibility is that UL11 travels to the plasma
membrane to promote the cell-to-cell spread of infection, either
by enabling the egress of vesicle-enclosed virions to the cell
surface or by promoting a direct interaction of the capsid (via
UL16) with the plasmamembrane. Further studies will be needed
to determine which (if any) of these models is correct.
Materials and methods
Cells and viruses
Vero and A7 melanoma cells were grown in Dulbecco's
Modified Eagle's Medium (DMEM, Invitrogen) supplemented
with 5% fetal bovine serum (FBS), penicillin, and streptomycin
(Gibco, 15140–148). Confluent Vero cells were infected with the
KOS strain ofHSV-1 (Smith, 1964) inDMEMsupplementedwith
2%FBS, 25mMHEPES buffer, glutamine (0.3μg/ml), penicillin,
and streptomycin. A recombinant virus expressing UL11-GFP
was created by homologous recombination. Sequences from
upstream and downstream of UL11 (350 bp each) were PCR
amplified from the viral genome and ligated to the 5′ and 3′
termini of UL11-gfp, respectively. The composite DNA fragment
was inserted into the pSP72 vector (Promega) and then co-
transfected into A7 cells with the genome of the KOS strain of
HSV-1. Recombinant virus was selected by five rounds of plaque
purification. The resulting virus was confirmed by a combination
of PCR analyses using primers that flank the UL11-gfp coding
sequence (yielding a larger product than untagged UL11) and the
failure to express the wild-type, untagged UL11, as determined by
Western blotting and radiolabeling/immunoprecipitating for
UL11. The recombinant was analyzed for specific infectivity
and plaque size, as well as localization and kinetics of UL11-GFP
expression. All characteristics examined were undiminished
compared to the parental virus (data not shown).
Antibodies
UL11-specific antibodies were developed in rabbits and have
been described previously (Loomis et al., 2003). GFP-specific
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obtained from rabbits injected with purified His6-GFP. The
specificity of this antibody was tested in both immunoblot and
immunoprecipitation assays (this study; data not shown).
Transferrin receptor antibodies were purchased from BD
Pharmingen (555534).
Membrane flotation
DRMs were isolated by using a slight modification of an
established protocol (Spearman et al., 1997). Briefly, the
calcium phosphate method was used to transfect human
melanoma (A7) cells with a plasmid containing UL11-gfp,
derived using the KOS strain of HSV-1 (Loomis et al., 2001).
After 16–18 h, the cells were radiolabeled with an L-[35S]
methionine-cysteine mix (75 μCi/ml, N1000 Ci/mmol) for
2.5 h, scraped off the plates, and washed in cold PBS. After
pelleting, the cells were resuspended and swollen in hypotonic
lysis buffer (10 mM Tris–HCl, pH 7.4, 0.2 mM MgCl2) on ice
for 30 min. They were lysed at 4 °C by 35 strokes with a dounce
homogenizer and then centrifuged at low speed to remove
unbroken cells and nuclei. Post-nuclear supernatants were split
into two equal aliquots, one untreated (for total membranes) and
the other adjusted to a concentration of 0.5% TX-100 (for
DRMs). In some experiments, samples were adjusted to 0.5%
SDS to disrupt all membranes (negative control). After
incubation on ice for 30 min, the samples were mixed with
65% (w/w) sucrose (58% final, 2.0 ml total), placed in the
bottom of a Beckman SW55 Ti tube, and sequentially overlaid
with 2.0 ml of 45% and 1.0 ml of 2.5% sucrose. Sucrose
solutions were made in NTE buffer (10 mM Tris–HCl, pH 7.4,
100 mMNaCl, 1 mM EDTA). The samples were centrifuged for
18 h at 200,000 ×g and 4 °C in a Beckman ultracentrifuge, and
six equal-volume fractions were collected from the top. UL11-
GFP was immunoprecipitated using rabbit anti-UL11 anti-
bodies (Loomis et al., 2003), separated by SDS-PAGE, and
quantitated by phosphorimager analysis.
Transferrin receptor and methyl-β-cyclodextrin treatment
To examine membrane localization of the endogenous
transferrin receptor (TfR), confluent monolayers of A7 cells
were radiolabeled with an L-[35S]methionine-cysteine mix
(300 μCi/ml, N1000 Ci/mmol) for 3 h. Following labeling,
cells were lysed, TX-100 treated, and floated as before. TfR was
immunoprecipitated from fractions using anti-TfR antibodies,
separated by SDS-PAGE, and quantitated by phosphorimager
analysis. Methyl-β-cyclodextrin (Sigma, C4555) was added to
A7 cells expressing either wild-type or mutant UL11-GFP
during the final hour of a 2.5 h label (75 μCi/ml, N1000 Ci/
mmol). DRM localized UL11 was then immunoprecipitated and
examined as before.
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